Since the effect of single high-dose radiotherapy depends on activation of DCs and an increase in tumor-specific effector CD8+ T cells [24], we speculated that combining radiotherapy with an EP4 antagonist would likely enhance treatment efficacy. The gene discussed is CD8A; the disease is neoplasm.